Points are assigned for family history of hyperlipidemia or premature coronary and/or vascular disease, clinical characteristics of tendon xanthomata, elevated LDL-C, and/or functional mutation of the LDLR, APOB, or PCSK9 genes. This evidence concerns the gene APOB and hyperlipidemia.